司美格鲁肽大卖。8月6日,诺和诺德发布2025年上半年财报。前6个月,诺和诺德销售达到1549.44亿丹麦克朗,以丹麦克朗计算增长16%,以固定汇率计算增长18%,经营利润以固定汇率计算增长29%,净利润达到555.37亿丹麦克朗。司美格鲁肽上半年销售额达到1127.56亿丹麦克朗,约167亿美元,超越K药。具体来看,降糖版司美格鲁肽注射液Ozempic销售额645.20亿丹麦克朗,减重版司美格...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.